CHE CHEMED CORP

NYSE chemed.com


$ 440.55 $ 9.64 (2.24 %)    

Friday, 17-Oct-2025 15:59:54 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 440.56
$ 435.59
$ 426.68 x 1
$ 450.00 x 5
$ 431.84 - $ 440.77
$ 407.86 - $ 622.20
147,258
na
6.42B
$ 0.44
$ 22.11
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2025 06-30-2025 10-Q
2 04-28-2025 03-31-2025 10-Q
3 02-28-2025 01-01-1970 10-K
4 11-01-2024 09-30-2024 10-Q
5 07-26-2024 06-30-2024 10-Q
6 04-29-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 10-27-2023 09-30-2023 10-Q
9 07-28-2023 06-30-2023 10-Q
10 04-28-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 07-29-2022 06-30-2022 10-Q
14 04-29-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-01-2021 09-30-2021 10-Q
17 07-30-2021 06-30-2021 10-Q
18 04-30-2021 03-31-2021 10-Q
19 02-26-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 07-31-2020 06-30-2020 10-Q
22 05-01-2020 03-31-2020 10-Q
23 02-26-2020 12-31-2019 10-K
24 11-04-2019 09-30-2019 10-Q
25 07-31-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 02-27-2019 12-31-2018 10-K
28 11-02-2018 09-30-2018 10-Q
29 07-30-2018 06-30-2018 10-Q
30 04-27-2018 03-31-2018 10-Q
31 02-26-2018 12-31-2017 10-K
32 10-27-2017 09-30-2017 10-Q
33 07-31-2017 06-30-2017 10-Q
34 04-28-2017 03-31-2017 10-Q
35 02-27-2017 12-31-2016 10-K
36 11-01-2016 09-30-2016 10-Q
37 07-29-2016 06-30-2016 10-Q
38 05-02-2016 03-31-2016 10-Q
39 02-26-2016 12-31-2015 10-K
40 10-30-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-of-a-securities-maintains-buy-on-chemed-lowers-price-target-to-595

B of A Securities analyst Joanna Gajuk maintains Chemed (NYSE:CHE) with a Buy and lowers the price target from $610 to $595.

 jefferies-upgrades-chemed-to-buy-raises-price-target-to-550

Jefferies analyst Brian Tanquilut upgrades Chemed (NYSE:CHE) from Hold to Buy and raises the price target from $490 to $550.

 chemed-board-formally-authorizes-additional-300m-for-stock-repurchase-raises-quarterly-cash-dividend-by-20-from-050-to-060-per-share

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million fo...

 rbc-capital-maintains-outperform-on-chemed-lowers-price-target-to-589

RBC Capital analyst Ben Hendrix maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $640 to $589.

 oppenheimer-maintains-outperform-on-chemed-lowers-price-target-to-580

Oppenheimer analyst Michael Wiederhorn maintains Chemed (NYSE:CHE) with a Outperform and lowers the price target from $650 t...

 chemed-appoints-joel-l-wherley-to-succeed-nicholas-m-westfall-as-vitas-ceo

After a successful sixteen-year career, Executive Vice President of Chemed and Chairman and Chief Executive Officer of VITAS, N...

 chemed-lowers-fy2025-adj-eps-guidance-from-2495-2545-to-2200-2230-vs-2333-est

Chemed (NYSE:CHE) lowers FY2025 Adj EPS guidance from $24.95-$25.45 to $22.00-$22.30 vs $23.33 analyst estimate..

 chemed-q2-adj-eps-427-misses-508-estimate-sales-61880m-miss-63403m-estimate

Chemed (NYSE:CHE) reported quarterly earnings of $4.27 per share which missed the analyst consensus estimate of $5.08 by 15.86 ...

 earnings-preview-for-chemed
Earnings Preview For Chemed
07/28/2025 19:02:05

 jefferies-initiates-coverage-on-chemed-with-hold-rating-announces-price-target-of-500

Jefferies analyst Brian Tanquilut initiates coverage on Chemed (NYSE:CHE) with a Hold rating and announces Price Target of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION